div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 10button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page10jpg target=_blank amp-img class=ts-thumb alt=Page 10: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails10jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 11button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page11jpg target=_blank amp-img class=ts-thumb alt=Page 11: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails11jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 12button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page12jpg target=_blank amp-img class=ts-thumb alt=Page 12: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails12jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 13button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page13jpg target=_blank amp-img class=ts-thumb alt=Page 13: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails13jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 14button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page14jpg target=_blank amp-img class=ts-thumb alt=Page 14: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails14jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 15button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page15jpg target=_blank amp-img class=ts-thumb alt=Page 15: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails15jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 16button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page16jpg target=_blank amp-img class=ts-thumb alt=Page 16: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails16jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 17button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page17jpg target=_blank amp-img class=ts-thumb alt=Page 17: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails17jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 18button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page18jpg target=_blank amp-img class=ts-thumb alt=Page 18: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails18jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 19button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page19jpg target=_blank amp-img class=ts-thumb alt=Page 19: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails19jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 20button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page20jpg target=_blank amp-img class=ts-thumb alt=Page 20: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails20jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 21button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page21jpg target=_blank amp-img class=ts-thumb alt=Page 21: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails21jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 22button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page22jpg target=_blank amp-img class=ts-thumb alt=Page 22: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails22jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 23button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page23jpg target=_blank amp-img class=ts-thumb alt=Page 23: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails23jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 24button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page24jpg target=_blank amp-img class=ts-thumb alt=Page 24: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails24jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 25button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page25jpg target=_blank amp-img class=ts-thumb alt=Page 25: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails25jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 26button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page26jpg target=_blank amp-img class=ts-thumb alt=Page 26: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails26jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 27button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page27jpg target=_blank amp-img class=ts-thumb alt=Page 27: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails27jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 28button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page28jpg target=_blank amp-img class=ts-thumb alt=Page 28: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails28jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 29button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page29jpg target=_blank amp-img class=ts-thumb alt=Page 29: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails29jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 30button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page30jpg target=_blank amp-img class=ts-thumb alt=Page 30: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails30jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 31button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page31jpg target=_blank amp-img class=ts-thumb alt=Page 31: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails31jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 32button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page32jpg target=_blank amp-img class=ts-thumb alt=Page 32: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails32jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 33button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page33jpg target=_blank amp-img class=ts-thumb alt=Page 33: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails33jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 34button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page34jpg target=_blank amp-img class=ts-thumb alt=Page 34: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails34jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 35button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page35jpg target=_blank amp-img class=ts-thumb alt=Page 35: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails35jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 36button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page36jpg target=_blank amp-img class=ts-thumb alt=Page 36: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails36jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 37button div class=ts-image a href=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5page37jpg target=_blank amp-img class=ts-thumb alt=Page 37: An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention src=https:reader039vdocumentsusreader039viewer20220219235a64b5ac7f8b9aa6148b4637html5thumbnails37jpg width=142 height=106 layout=responsive amp-imga divdiv